MD Anderson Cancer Center

Phase	Trial	Trial Status	Site Status [desc]	Drug	NCT#
1	A Study of the C-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced And/or Metastatic Solid Tumors Known to Express C-Kit	Recruiting	Active	NN3201	NCT06805825